Amy Li

Amy Li is a clinical trial specialist at Verve Therapeutics. Prior to joining Verve, she worked as a clinical research associate on hATTR polyneuropathy trials at Ionis Pharmaceuticals and on phase 2 clinical programs targeting APOCIII and ANGPTL3 at Akcea Therapeutics, as a clinical trial associate. Amy received her B.S. in Biology and Community Health from Tufts University and her M.P.H. in Epidemiology from Boston University.